scientists at yale university in connecticut in the us have revealed how the treatment , called azdo5030 , restored memory in mice given alzheimer 's disease .
the drug was developed by the british pharmaceutical giant astra zeneca with the original aim of treating certain types of tumour , but was shelved after it proved ineffective .
the study has led to the launch of human trials to test the efficacy of the drug in alzheimer 's patients .